Clinical correlates of tardive dyskinesia in schizophrenia: baseline data from the CATIE schizophrenia trial.
about
Quetiapine versus other atypical antipsychotics for schizophreniaAntipsychotic drug treatment for elderly people with late-onset schizophreniaZiprasidone versus other atypical antipsychotics for schizophreniaPharmacogenetics of antipsychotic adverse effects: Case studies and a literature review for cliniciansGenomewide association for schizophrenia in the CATIE study: results of stage 1Extrapyramidal side-effects of antipsychotics in a randomised trial.Antipsychotic-induced vacuous chewing movements and extrapyramidal side effects are highly heritable in mice.Tardive dyskinesia in relation to estimated dopamine D2 receptor occupancy in patients with schizophrenia: analysis of the CATIE data.World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Substance Use and Related Disorders, Part 1: Alcoholism.A meta-analysis of the risk of acute extrapyramidal symptoms with intramuscular antipsychotics for the treatment of agitation.The incidence of tardive dyskinesia in the study of pharmacotherapy for psychotic depression.Aging in fragile X syndrome.Movement disorders induced by antipsychotic drugs: implications of the CATIE schizophrenia trialNew pharmacological approaches for the treatment of alcoholism.Gray matter abnormalities in schizophrenia patients with tardive dyskinesia: a magnetic resonance imaging voxel-based morphometry study.Incidence of tardive dyskinesia with atypical versus conventional antipsychotic medications: a prospective cohort studyGuidelines for biological treatment of substance use and related disorders, part 1: Alcoholism, first revision.Concomitant medication of psychoses in a lifetime perspective.Tardive dyskinesia and essential fatty acids.Are second generation antipsychotics a distinct class?Genetic determinants of variable metabolism have little impact on the clinical use of leading antipsychotics in the CATIE study.Genetic underpinnings of tardive dyskinesia: passing the baton to pharmacogenetics.Treatment outcomes of patients with tardive dyskinesia and chronic schizophrenia.The latent structure of psychiatric symptoms across mental disorders as measured with the PANSS and BPRS-18.Off-label antipsychotic use and tardive dyskinesia in at-risk populations: new drugs with old side effectsA candidate gene study of Tardive dyskinesia in the CATIE schizophrenia trialDiabetes is associated with lower global cognitive function in schizophreniaMeasuring negative symptom change in schizophrenia: considering alternatives to self-report.Pharmacogenetics of tardive dyskinesia: an updated review of the literature.Interpreting and Applying the CATIE Results: With CATIE, context is key, when sorting out Phases 1, 1A, 1B, 2E, and 2T.Prevalence of neuroleptic-induced movement disorders: an 8-year follow-up study in chronic schizophrenia inpatients.Clozapine-induced tardive dyskinesia in schizophrenic patients taking clozapine as a first-line antipsychotic drug.A Cross-Sectional Study on the Characteristics of Tardive Dyskinesia in Patients with Chronic Schizophrenia.Prevalence and pattern of antipsychotic induced movement disorders in a tertiary care teaching hospital in India - a cross-sectional study.Tardive dyskinesia: motor system impairments, cognition and everyday functioning.The Black Book of Psychotropic Dosing and Monitoring.Acculturation is associated with the prevalence of tardive dyskinesia and akathisia in community-treated patients with schizophrenia.Antipsychotic-induced parkinsonism is associated with working memory deficits in schizophrenia-spectrum disorders.Management of common adverse effects of antipsychotic medications
P2860
Q24202427-1D30FB03-CCF4-4E5F-BCD1-26FBE8E1982CQ24203649-8712C362-EA19-43A6-B668-6745EA7B5BEBQ24240260-B44F013F-169E-41CE-938F-AEEFF9819BFAQ24657338-7A99F81B-BB7B-4698-9810-6DF9958360F8Q28659652-F05C9F47-02FB-4C6C-8087-3D76C9EACC9BQ30492645-AC287C67-B772-4B42-9DB5-37E3BA681C5AQ30501284-C581892F-3EB9-47F6-AF86-606D6C737A00Q30747608-9F3B34BD-6458-45BD-80A0-1E89618E78E6Q33319816-6AB9EB4B-CAE7-40B5-987E-DD749CEE5835Q33699874-681FBDC5-55BB-46E0-93FA-C16BBD3BD7FDQ33770747-F42B5B57-95C5-4E58-94BE-1190C22D40F4Q33901217-46C59622-CE46-4CCD-8D96-B7ABF9210C47Q34480263-D51BA8EA-01F3-4A4F-800E-CD51F639248BQ34582243-C476E7FB-66E3-4F76-AE67-83744DE26FECQ34963355-14D21489-50CA-4D9B-9C5D-1FC5DF77139EQ35030003-A2B0A027-EFCC-4245-BF92-C22A8923F0D3Q36231851-7BCC8458-CE41-41DC-AA7D-11D07A7B51E7Q36420453-50C0C6EB-AD6C-4091-86DE-F9A1A2679F20Q36508056-3E6B7D7D-0246-4E39-87B4-F71A44405911Q36784527-86B0C81A-B332-465E-B8CD-8C3040CAFB5DQ36969067-F07ACAC9-B81A-4D6F-9EB0-22542D9EB3D7Q37264543-A0FC31D5-0C59-4C5C-A882-9510C1D97D8FQ37302639-F27D3102-812E-41CB-9800-68A8E405E830Q37344831-849DA81E-A2C0-4029-BFDE-09F8CAB5234EQ37416376-310A401B-AFEA-4F63-92F0-747E63FACEB2Q37489656-4B2582A5-D70B-4197-8924-5D3617A0C31EQ37731448-A458353C-62A0-4306-8A27-84654B220886Q38224360-703F08A4-BC42-4001-B078-D2FB3CE78A7EQ38911685-32708B95-8D08-454A-8BD1-FA6A59377E5FQ40224374-4414930D-0E82-4A44-A700-8E659B265873Q40792368-483A86EB-F1FB-4CEB-A755-17826C57FE21Q43227531-D99246D0-4144-44A2-8B4A-F3F732C83B71Q47105526-7304651D-C835-4B8B-8647-A8D9387CBED9Q47627363-3AF74707-5B3C-477E-9C1F-540FBE36D3ACQ47628451-10F5B544-ADE5-4545-BD5E-22A630286D37Q47642128-0F674685-EC27-4493-8650-18F064E8C5B4Q47686979-7D602EA8-4FE9-43CB-8322-2AA46860B482Q48274723-3C238E18-0748-4E0E-A091-A1296D023A05Q58760350-0179D864-DF70-4C65-A926-73CEF59DE1B4
P2860
Clinical correlates of tardive dyskinesia in schizophrenia: baseline data from the CATIE schizophrenia trial.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Clinical correlates of tardive ...... the CATIE schizophrenia trial.
@ast
Clinical correlates of tardive ...... the CATIE schizophrenia trial.
@en
type
label
Clinical correlates of tardive ...... the CATIE schizophrenia trial.
@ast
Clinical correlates of tardive ...... the CATIE schizophrenia trial.
@en
prefLabel
Clinical correlates of tardive ...... the CATIE schizophrenia trial.
@ast
Clinical correlates of tardive ...... the CATIE schizophrenia trial.
@en
P2093
P50
P1476
Clinical correlates of tardive ...... the CATIE schizophrenia trial
@en
P2093
Bruce L Saltz
Joseph P McEvoy
Marvin S Swartz
Miranda H Chakos
Richard S E Keefe
Robert A Rosenheck
Sonia M Davis
Stanley N Caroff
P356
10.1016/J.SCHRES.2005.07.034
P407
P577
2005-09-19T00:00:00Z